• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0
×

Target

Host

Species Reactivity

Species Reactivity

Conjugate

Conjugate

  • HEK293 expressed
  • Endotoxin-free
  • Animal-component free

HumanKine® recombinant human BDNF protein

Activity

4-40 ng/mL

Specific Activity

minimally 3.00 x105 IU/mg

Species Reactivity

human

Purity

>95%

Cat no : HZ-1335

Synonyms

Abrineurin, ANON2, brain-derived neurotrophic factor

Validation Data Gallery

  • Purity of recombinant human BDNF was determined by SDS- polyacrylamide gel electrophoresis. The protein was resolved in an SDS- polyacrylamide gel in reducing and non-reducing conditions and stained using Coomassie blue.

    Purity of recombinant human BDNF was determined by SDS- polyacrylamide gel electrophoresis. The protein was resolved in an SDS- polyacrylamide gel in reducing and non-reducing conditions and stained using Coomassie blue.

  • BDNF stimulates dose-dependent proliferation of the SH-SY5Y Neuroblastoma cell line. SH-SY5Y cells were treated with increasing concentrations of recombinant BDNF for 72 hours after an initial 5 day incubation with 10 μM retinoic acid. Viable cell number was quantitatively assessed by PrestoBlue® Cell Viability Reagent. The EC50 was determined using a 4-parameter non-linear regression model. The EC50 range is < 100 ng/mL.

    BDNF stimulates dose-dependent proliferation of the SH-SY5Y Neuroblastoma cell line. SH-SY5Y cells were treated with increasing concentrations of recombinant BDNF for 72 hours after an initial 5 day incubation with 10 μM retinoic acid. Viable cell number was quantitatively assessed by PrestoBlue® Cell Viability Reagent. The EC50 was determined using a 4-parameter non-linear regression model. The EC50 range is < 100 ng/mL.

  • Proteintech BDNF (Cat no: HZ-1335) demonstrates equivalent fold induction and a greater than 5-fold increase in potency compared to leading competitors. BDNF stimulates dose-dependent proliferation of the SH-SY5Y Neuroblastoma cell line. SH-SY5Y cells were treated with increasing concentrations of recombinant BDNF for 72 hours after an initial 5 day incubation with 10 μM retinoic acid. Viable cell number was quantitatively assessed by PrestoBlue® Cell Viability Reagent. The EC50 was determined using a 4-parameter non-linear regression model. The EC50 range is < 100 ng/mL.

    Proteintech BDNF (Cat no: HZ-1335) demonstrates equivalent fold induction and a greater than 5-fold increase in potency compared to leading competitors. BDNF stimulates dose-dependent proliferation of the SH-SY5Y Neuroblastoma cell line. SH-SY5Y cells were treated with increasing concentrations of recombinant BDNF for 72 hours after an initial 5 day incubation with 10 μM retinoic acid. Viable cell number was quantitatively assessed by PrestoBlue® Cell Viability Reagent. The EC50 was determined using a 4-parameter non-linear regression model. The EC50 range is < 100 ng/mL.

  • Differentiation of SHSY5Y cells into neurons using HumanKine BDNF in the presence of Retinoic acid. The data demonstrates significantly better neuronal differentiation using HumanKine BDNF compared to leading competitor in the market.

    Differentiation of SHSY5Y cells into neurons using HumanKine BDNF in the presence of Retinoic acid. The data demonstrates significantly better neuronal differentiation using HumanKine BDNF compared to leading competitor in the market.

Technical Specifications

GeneID 627
Species Human
Expression HEK293
Activity 4-40 ng/mL
Specific Activityminimally 3.00 x105 IU/mg
Purity >95%
Endotoxin<1 EU/μg
Accession NumberP23560
Molecular Mass 14 kDa reduced and non-reduced, homodimer, non-glycosylated
Formulation 10 x PBS pH 7.4 See Certificate of Analysis for details
Species Reactivity human

Stability and Reconstitution

Stability and Storage Lyophilized proteins are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.
Reconstitution Briefly centrifuge the vial before opening. It is recommended to reconstitute the protein to 0.2 mg/mL in sterile 1x PBS pH 7.4 containing 0.1% endotoxin-free recombinant human serum albumin (HSA). Gently swirl or tap vial to mix.

Background

Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family, which also includes NGF, NT-3, NT-4, and NT-6. It plays a critical role in the survival, differentiation, and maturation of neurons during development. It is primarily expressed in various regions of the brain including the hippocampus, amygdala, cerebellum, and cerebral cortex. BDNF binds with the TrkB receptor, which results in the activation of downstream pathways controlling neural plasticity, neurogenesis, and stress resistance. It may also play a role in promoting angiogenesis and endothelial cell survival. Decreased levels of BDNF have been associated with several neurodegenerative diseases such as Parkinson’s, multiple sclerosis, and Huntington’s disease.

Synonyms

Abrineurin, ANON2, brain-derived neurotrophic factor

Publications

SpeciesTitle
human

Hum Cell

Establishment and characterization of ZJUCHi003: an induced pluripotent stem cell line from a patient with Temple-Baraitser/Zimmermann-Laband syndrome carrying KCNH1 c.1070G > A (p.R357Q) variant

Authors - Die Chen
View Article